文献速递乳腺MR

低剂量成像技术(LITE)MRI:乳腺成像的初步经验

Low-dose imaging technique (LITE) MRI: initial experience in breast imaging.
PubMed 文献 · Br J Radiol · 2019-07-11

本研究对8例女性共10个符合纤维腺瘤影像特征的病灶行双剂量注射动态增强乳腺MRI,比较低剂量与标准剂量图像。低剂量与标准剂量图像均显示全部9个强化病灶,低剂量图像病灶 conspicuity 和强化率更高,标准剂量图像强化上限和信噪比更高。作者认为LITE MRI有潜力在强化病灶检出上匹配标准DCE-MRI,并可能提高对对比剂动力学的敏感性。

要点

  • 低剂量与标准剂量图像均检出全部9个强化病灶,1个病灶两期均无强化。
  • 低剂量图像病灶 conspicuity 和强化率高于标准剂量,比值分别为1.5±0.1和1.2±0.4。
  • 标准剂量图像强化上限和信噪比更高,比值分别为0.3±0.1和0.5±0.1。

核心结论

  • 本初步研究显示LITE MRI有潜力在强化病灶检出上匹配标准DCE-MRI,并可能提高对对比剂动力学的敏感性。
  • 较低剂量MRI对比剂可能在乳腺病灶检出中同样有效,并增加对对比剂动力学的敏感性。
  • LITE MRI可能有助于提高筛查依从性和长期患者安全。

研究设计与样本

  • 初步研究,纳入8例女性共10个影像特征符合纤维腺瘤的病灶。
  • 采用双剂量动态增强MRI技术:预扫描后注射标准剂量的15%,约10分钟后注射剩余85%的标准剂量。
  • 定量测量强化动力学参数、病灶 conspicuity 和信噪比。

关键影像表现/征象

  • 1个病灶在两个DCE序列中均无强化。
  • 全部9个强化病灶在低剂量和标准剂量图像中均可见。
  • 低剂量与标准剂量对比剂剂量比值约为0.18,但未匹配动力学参数比值。
  • 低剂量图像病灶 conspicuity 和强化率均更高,低剂量与标准剂量比值分别为1.5±0.1和1.2±0.4。
  • 标准剂量图像强化上限和信噪比更高,低剂量与标准剂量比值分别为0.3±0.1和0.5±0.1,但低于基于剂量比值的预期。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To compare a low-dose dynamic contrast-enhanced breast MRI protocol (LITE MRI) to standard-dosage using a dual-dose injection technique.

METHODS: 8 females with a total of 10 lesions with imaging features compatible with fibroadenoma were imaged using a dual-dose dynamic contrast-enhanced-MRI (DCE-MRI) technique. After pre-contrast scans, 15% of a standard dose of contrast was administered; approximately 10 min later, the remaining 85% of the standard dose was administered. Enhancement kinetic parameters, conspicuity and signal-to-noise ratio were measured quantitatively.

RESULTS: One lesion showed no enhancement in either DCE series. All nine of the enhancing lesions were visualized in both the low-dose and standard-dose images. While the (low-to-standard) ratio of contrast doses was roughly 0.18, this did not match the ratios of kinetic parameters. Lesion conspicuity and enhancement rate were both higher in the low-dose images, with (low-to-standard) ratios 1.5 ± 0.1 and 1.2 ± 0.4, respectively. The upper limit of enhancement (ratio 0.3 ± 0.1) and signal-to-noise ratio (ratio 0.5 ± 0.1) were higher in the standard-dose images, but less than expected based on the ratio of the doses.

CONCLUSIONS: This preliminary study demonstrates that LITE MRI has the potential to match standard DCE-MRI in the detection of enhancing lesions. Additionally, LITE MRI may enhance sensitivity to contrast media dynamics.

ADVANCES IN KNOWLEDGE: Lower doses of MRI contrast media may be equally effective in the detection of breast lesions, and increase sensitivity to contrast media dynamics. LITE MRI may help increase screening compliance and long-term patient safety.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Pineda F, Sheth D, Abe H, et al. Low-dose imaging technique (LITE) MRI: initial experience in breast imaging. Br J Radiol. 2019. PMID: 31271535. doi:10.1259/bjr.20190302

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。